Senior insider sale
Chief Scientific Officer at NUVALENT, INC. — senior position signals high conviction
$584.5K
5.20K shares
What this filing means
PELISH HENRY E. plans to sell 5.20K shares of NUVALENT, INC. valued at approximately $584.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0002029477-26-000006
Officer· Chief Scientific Officer
Since Mar 2026
5.20K
Shares to sell
$584.5K
Approx. market value
2.11K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
7/9/2026
2.11KTotal acquired2.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/9/2026 | Restricted Stock Unit Vesting Equity Compensation | 2.11K | — |
| Total | 2.11K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.09K
Market value
$323.2K
4/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.11K
Market value
$261.4K
7/9/2026
Total
Units
5.20K
Value
$584.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/9/2026 | 3.09K | $323.2K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 2.11K | $261.4K | NASDAQ | Planned |
| Total | 5.20K | $584.5K | ||